News
Portzamparc Groupe BNP Paribas Initiates the Coverage of Median Technologies with a “Strong Buy” Recommendation
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering
Median Technologies to Host Two Webcasts and Provide a Company Update on July 20, 2023
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on July 20, 2023 during
Median Technologies Announces Onboarding of All Academic Sites Involved in the Pivotal Validation Plan for iBiopsy® LCS CADe/CADx SaMD
Regulatory News:
Median Technologies (ALMDT) announces today that the Company has officially commenced operations with all investigator sites participating in the pivotal validation plan for its
Median Technologies Reports Its Business Activity for the First Half of 2023 and Announces the First Step of Its Refinancing Plan
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) reports today its business indicators for the first half of 2023 for the iCRO activity (non-audited figures) and the iBiopsy®
BILENDI: Bilendi launches groundbreaking, AI-supported research platform
Median Technologies Announces the Availability of the Preparatory Documents for the Shareholders’ Ordinary and Extraordinary General Meeting on June 20, 2023
Regulatory News:
The shareholders of Median Technologies (ALMDT:PA) (Paris:ALMDT) are invited to participate at the Shareholders’ Ordinary and Extraordinary General Meeting which will be held on
BILENDI: Q1 2023 revenues: €13.8 million up +3%, +4.4% at constant exchange rates
Median Technologies to Host Two Webcasts and Provide a Company Update on May 3, 2023
Regulatory News:
Median Technologies (ALMDT:PA) announced today that Fredrik Brag, CEO and Founder of Median Technologies, will provide a company update on May 3rd, 2023 during two webcasts:
Median Technologies Reschedules Its Corporate Update Webcasts on May 4, 2023
Regulatory News:
Median Technologies (ALMDT:PA) announced today that the two webcasts during which Fredrik Brag, CEO and Founder will provide a corporate update, are rescheduled from May 3rd to
Median Technologies Reports Full-year 2022 Results and Business Indicators for the First Quarter Of 2023
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) (Paris;ALMDT) whose Board of Directors met on April 19, 2023 to approve the consolidated financial statements for the financial
BILENDI: 2022 results: Strong increase in profitability
Median Technologies to present new and breakthrough results for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device at the European Congress of Radiology, taking place March 1-5 2023 in Vienna, Austria
Regulatory News:
Median Technologies (ALMDT:PA) today announces new and breakthrough results for its iBiopsy® Lung Cancer Screening (LCS) AI/ML tech-based CADe/CADx1 Software as Medical Device
Median Technologies Announces Completion of the Q-Submission Phase with the FDA for its iBiopsy® Lung Cancer Screening CADe/CADx Software as Medical Device
Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announces today that the Company has received feedback from the United States Food and Drug Administration (FDA) regarding the
Median Technologies to Participate in the Cowen’s 43rd Annual Health Care Conference
Regulatory News:
Median Technologies (Paris:ALMDT), will be participating in the Cowen’s 43rd Annual Health Care Conference, taking place on March 6 – 8 ,2023, at the Boston Marriott Copley Place
BILENDI: 2022 : record revenues of €61.5 million (+39.5%)
Median Technologies to Host Two Webcasts and Provide a Company Update on February 2, 2023
Regulatory News:
Median Technologies (ALMDT:PA) (Paris:ALMDT) announced today that Fredrik Brag, CEO and founder of Median Technologies, will provide a company update on February 2nd, 2023 during
Median Technologies Announces 2022 Revenue of €23.8 Million, up 16%, and an Order Backlog of €60.8 Million
Regulatory News:
Median Technologies (ALMDT:PA) announces its revenue level for the full year 2022.
“In 2022, revenue generated by the iCRO business continued to grow in double digits. Our new
Median Technologies: Financial Communications Schedule for the First Half of 2023
Regulatory News:
Median Technologies (ALMDT:PA) (Paris:ALMDT), announces the publication date for its 2022 results:
Publication
Date
2022 results
April 20, 2023*
Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations
Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be speaking and presenting at the world’s largest medical imaging conference, the 2022
BILENDI: Revenues for the 3rd quarter of 2022: +41.9%
Median Technologies Announces Its 2022 Half-year Results and Revenues for the Third Quarter
Regulatory News:
Median Technologies (Euronext Growth - ALMDT) (Paris:ALMDT), whose Board of Directors approved on October 18, 2022 the consolidated IFRS financial statements for the first half
BILENDI: Very strong growth in results for H1 2022
Median Technologies Announces Formation of Clinical Advisory Board for iBiopsy® Lung Cancer Screening
Regulatory News:
Median Technologies (Paris:ALMDT) announced today the formation of their Clinical Advisory Board (CAB) for iBiopsy® Lung Cancer Screening. This group of world class physicians
Median Technologies to Participate in the 2022 ESMO Congress, Sep 9 – 13, 2022, Paris, France, With Two Scientific Posters on iCRO and iBiopsy®
Regulatory News:
Median Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be participating in the 2022 ESMO (European Society for Medical Oncology) Congress, to be held in